Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions (2016 - 2018)

China Pharma Holdings' Tax Provisions history spans 9 years, with the latest figure at $1921.0 for Q4 2018.

  • For Q4 2018, Tax Provisions fell 93.71% year-over-year to $1921.0; the TTM value through Dec 2018 reached -$109989.0, down 189.69%, while the annual FY2018 figure was -$109989.0, 189.69% down from the prior year.
  • Tax Provisions reached $1921.0 in Q4 2018 per CPHI's latest filing, up from -$160485.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $243131.0 in Q4 2016 to a low of -$160485.0 in Q3 2018.
  • Average Tax Provisions over 5 years is $8447.8, with a median of $1921.0 recorded in 2018.
  • Peak YoY movement for Tax Provisions: skyrocketed 8718.61% in 2016, then crashed 614.41% in 2018.
  • A 5-year view of Tax Provisions shows it stood at -$19284.0 in 2014, then skyrocketed by 85.37% to -$2821.0 in 2015, then surged by 8718.61% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then tumbled by 93.71% to $1921.0 in 2018.
  • Per Business Quant, the three most recent readings for CPHI's Tax Provisions are $1921.0 (Q4 2018), -$160485.0 (Q3 2018), and $22590.0 (Q2 2018).